Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing SAN...
FRAMINGHAM, MA / ACCESS Newswire / January 21, 2025 / New Horizons Medical (NHM), a leader in healthcare for dually...
Established Program Broadens Its Range of Services to Meet the Growing Demand for High-Quality Substance Use Disorder and Mental Health...
The Mexico-based hormone clinic, which has online capabilities is doing its part to meet increased global demand for affordable Human...
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
The Mexico-based hormone clinic, which has online capabilities is doing its part to meet increased global demand for affordable Human...
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
Free to participants in the 2025 survey of BHIT software, this comprehensive report offers critical insights into trends, developments, and...
Free to participants in the 2025 survey of BHIT software, this comprehensive report offers critical insights into trends, developments, and...
FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company...
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters...
The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary hyperhidrosis...
SCOTTSDALE, Ariz., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a...
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / In an era where mental health challenges continue...
FORT WORTH, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis...
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Nation’s leading compound pharmacy is now available in 48 statesORLANDO, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a...
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in cloud-connected bioprocessing technologies, is...
GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development...